Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Herceptin
Pharma
Roche bolsters Perjeta's case with ten-year breast cancer data
Roche's Perjeta, Herceptin and chemotherapy regimen cut the risk of death by 17% in patients with early-stage HER2-positive breast cancer.
Zoey Becker
May 13, 2025 11:23am
Roche settles UPenn patent lawsuit over breast cancer drugs
Mar 14, 2025 3:00pm
Merck's Keytruda mostly won out at ESMO, with one notable miss
Oct 24, 2023 9:05am
Genentech lays off 280 as first biologics plant winds down
Mar 23, 2023 9:40am
Roche pharma CEO Anderson leaves in another leadership shuffle
Dec 12, 2022 9:52am
Seagen's Tukysa picks up FDA priority review in Herceptin combo
Sep 20, 2022 10:59am
